Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 106 of 106 publications.

Ettinger B, Earnshaw SR, Brogan AJ, Graham CN, Amonkar MM, Baran R. Modeled cost impact of persistence with bisphosphonate therapy for women with postmenopausal osteoporosis. Poster presented at the Academy of Managed Care Pharmacy 17th Annual Meeting & Showcase; April 23, 2005.

Earnshaw SR, Brogan AJ, Graham CN, Amonkar MM, Baran R, Hebborn A. The impact of persistency on economic models for bisphosphonate therapy in osteoporosis. Poster presented at the 5th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis; March 26, 2005. Rome, Italy.

Strickland A, Brogan AJ, Krauss J, Martindale R, Cresci G. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. J Parenter Enter Nutr. 2005 Jan 1;29(1 Suppl):S81-91.

Brogan AJ, Mauskopf JA, Quattek K, Jordan J. Lower resource use of 908/ritonavir compared to nelfinavir may be explained by better tolerability. Poster presented at the 42nd Annual Meeting of the Infectious Disease Society of America; October 2004.

Brogan AJ, Stidham S. Portfolio optimization risk measures: variance versus target semivariance. Presented at the Annual Meeting of the Institute for Operations Research and Management Science; November 2002.